United States Food and Drug Administration (USFDA) has conducted inspection at the Unichem Laboratories’ Pithampur, Active Pharmaceutical Ingredients (APIs) facility from September 02, 2019 to September 05, 2019. The inspection was a post approval inspection and successfully concluded without any USFDA form 483 issued.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
